Fresh analysis suggests that patients who come off blockbuster weight-loss injections like Mounjaro or Wegovy may regain shed pounds far faster than those who end conventional lifestyle plans.
Research printed in a prominent health publication demonstrates that while obese individuals frequently drop about a fifth of their body weight while using the jabs, the mass returns at an average rate of 0.8 kg per month upon discontinuation.
"People purchasing these medications need to be informed of the potential of fast rebound weight gain when the treatment concludes," cautioned researcher Dr. Susan Jebb.
Such speed of recovery means a reversion to pre-treatment mass within about one and a half years.
Comparing Treatments
The research, which reviewed dozens of trials involving over 9,000 of patients, compared the effects of these new drugs with other pills.
The team point out that people who lose weight through lifestyle changes alone typically experience a slower creep back—around 100 grams monthly—after stopping.
Understanding the Quick Regain
Experts suggest the mode of action of the jabs accounts for the amplified regain.
The injections copy a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Long-term administration of GLP-1 levels far above than the body's typical production might result in the system to produce less of its endogenous hormone, and could reduce responsiveness to its effects," noted Dr. Adam Collins, a nutrition expert.
"Withdrawal of this medication means appetite is no longer kept in check, making overeating far more likely."
A Chronic Condition?
Medical guidelines suggest the jabs for individuals with obesity-related health risks, alongside recommended diet and exercise modifications.
A number of clinicians argue that, given the high risk of weight regain, the therapy should be considered ongoing.
This perspective is supported by drug manufacturers, who state that the findings "emphasize the long-term nature of excess weight," similar to managing diseases like high blood pressure.
Patient Testimonies
Individuals who have come off the jabs report a sudden return of hunger.
"It felt as if a trigger activating and I was suddenly starving," recalled one woman.
This challenge is exacerbated if users have not established sustainable lifestyle or habit changes during therapy.
Significant Adoption
Survey data suggest that millions of people in the UK have used these injections in the last 12 months, with desire continuing to grow.
- Use is more common among females compared to men.
- The middle-aged age group shows the highest level of interest.
- Many obtain the drugs through private prescriptions rather than the NHS.
Finally, experts emphasize that while GLP-1 drugs are potent agents for shedding pounds, they are not a permanent solution and maintained weight loss likely depends on ongoing lifestyle changes.
